Anti-tumour effects by a trimodal combination of temozolomide, meloxicam and X-rays in cultures of human glioma cells

By Van Nifterik Krista A.   Van Den Berg Jaap   Slotman Ben J.   Van Rijn Johannes  

International Journal of Radiation Biology, Vol. 87, Iss. 2, 2011-02 ,pp. : 192-201

Informa Healthcare

Access to resources Recommend Favorite

Combination therapy of gemcitabine or oral S-1 with the anti-VEGF monoclonal antibody bevacizumab for pancreatic neuroendocrine carcinoma

By                    

Experimental and Therapeutic Medicine, Vol. 3, Iss. 4, 2012-01 ,pp. : 599-602

Spandidos Publications

Access to resources Recommend Favorite

Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma

By Lu Kan V   Bergers Gabriele  

CNS Oncology, Vol. 2, Iss. 1, 2013-01 ,pp. : 49-65

Future Medicine

Access to resources Recommend Favorite

Targeting Vascular Endothelial Growth Factor (VEGF) for Anti-tumor Therapy, by Anti-VEGF Neutralizing Monoclonal Antibodies or by VEGF Receptor Tyrosine-kinase Inhibitors

By Schlaeppi J-M.  

Cancer and Metastasis Reviews, Vol. 18, Iss. 4, 1999-12 ,pp. : 473-481

Springer Publishing Company

Access to resources Recommend Favorite

The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells

By Ping Yi-fang   Yao Xiao-hong   Chen Jian-hong   Liu Hong   Chen Dai-lun   Zhou Xiang-dong   Wang Ji   Bian Xiu-wu  

Journal of Neuro-Oncology, Vol. 84, Iss. 1, 2007-08 ,pp. : 21-29

Springer Publishing Company

Access to resources Recommend Favorite